Sodium-Glucose Co-Transporter-2 Inhibitors Sodium-glucose co-transporter-2 (SGLT-2) inhibitors are currently licensed for the treatment of T2D, though there is a growing body of evidence to support their use in cardiovascular [56] and renal disease [57]
Most people find them most helpful during their largest meal of the day or when consuming protein-heavy meals
Resting-state functional images will be obtained using a gradient-echo echo-planar imaging (EPI) sequence with the following parameters: repetition time (TR) 2000 ms, echo time (TE) 30 ms, flip angle 90, field of view 220 220 mm, matrix size 64 64, slice thickness 3.5 mm, and no inter-slice gap
That distinction is the single biggest driver of whether a request is approved
This research was funded by grants from the National Natural Science Foundation of China (NSFC) (No
442 Research into ketamine actions in the CNS revealed multiple effects, including potentiation of synaptogenesis, increased density of dendritic spines and upregulation of postsynaptic levels of AMPA receptors